Ledger.Open graph →

SEC Form D · Amendment · filed September 27, 2016

Banyan Biomarkers, Inc

Offering

$10.0M

Sold

$3.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

San Diego, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Nancy Denslow, Ph.D · San Diego, CADirector Stanford Warshawsky · San Diego, CADirector Henry Nordhoff · San Diego, CAExec · Director Ronald Hayes, Ph.D · San Diego, CAExec · Director Julie Pashkowsky · San Diego, CAExec Steven Richieri · San Diego, CAExec · Director Andrew Von Eschenbach, M.D · San Diego, CADirector Tony Grover · San Diego, CAExec William Roper, Jr · San Diego, CADirector Heiner Dreismann · Seattle, WAExec Peter K. Farrell, Ph.D · Cambridge, MADirector Ben Malka · San Rafael, CADirector Harold Kawaguchi · Seattle, WAExec · Director Michael Flaherty · Los Angeles, CAExec · Director Darin Glatt · Portland, ORExec Stephen Rose · Seattle, WADirector Peter B. Finn, Esq · Boston, MAExec · Director Allan Stephan · Seattle, WADirector Norman Flagg · San Diego, CADirector Jackson Streeter · San Diego, CAExec · Director Marcus K. Semones, Ph.D · Cambridge, MAExec · Director Xiaoqing Xu · Central, Hong KongDirector Tyler Mckinley · Portland, ORExec · Director David M. Klubert · Huntsville, ALDirector Dominik M. Aronsky · Huntsville, ALExec James B. Kelly · Huntsville, ALExec · Director William Nelson, Jr · San Rafael, CADirector Scott Winters · San Rafael, CAExec Will K. Young · Las Vegas, NVDirector Norman Flagg · San Diego, CADirector Jackson Streeter · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗